Back to results
US 2012/0071479 A1Published application
Pyrazine derivatives as enac blockers
AssigneeNovartis AG
InventorsGurdip Bhalay, Lee Edwards, Catherine Howsham, Peter Hunt, Nichola Smith
Life of this patent
Estimating the term…
Abstract
Compounds of Formula I: and pharmaceutically acceptable salts and solvates thereof, wherein R1, R2, R3, R4, R5, R6, R7, R8, R9, and R10 have the meanings as indicated in the specification, are useful for treating diseases mediated by blockade of the epithelial sodium channel. Pharmaceutical compositions that contain the compounds and processes for preparing the compounds are also described.
Claims12
A compound of Formula I:
- or a pharmaceutically acceptable salt thereof, wherein
- R1 is H, halogen, C1-C8-alkyl, C1-C8-haloalkyl, C1-C8-haloalkoxy, C3-C15-carbocyclic group, nitro, cyano, a C6-C15-membered aromatic carbocyclic group, or a C1-C8-alkyl substituted by a C6-C15-membered aromatic carbocyclic group;
- R2, R3, R4 and R5 are each independently selected from H and C1-C6 alkyl;
- R6, R7, R8 and R9 are each independently selected from H;
- SO2R16;
- aryl optionally substituted by one or more Z groups;
- a C3-C10 carbocyclic group optionally substituted by one or more Z groups;
- C3-C14 heterocyclic group optionally substituted by one or more Z groups;
- C1-C8 alkyl optionally substituted by an aryl group which is optionally substituted by one or more Z groups, a C3-C10 carbocyclic group optionally substituted by one or more Z groups or a C3-C14 heterocyclic group optionally substituted by one or more Z groups;
- R10 is represented by the formula 2:
- —(C0-C3alkylene)-B—X—(CR11aR12a)m—(CR11bR12b)n—(CR11cR12c)p—C(O)OR13,
- wherein the alkylene groups are optionally substituted by one or more Z groups;
- B is aryl optionally substituted by one or more Z groups;
- X is selected from a bond, —NR15(SO2)—, —(SO2)NR15—, —(SO2)—, —NR15C(O)—, —C(O)NR15—, —NR15C(O)NR17—, —NR15C(O)O—, —NR15—, C(O)O, OC(O), C(O), O and S;
- R11a, R11b, R11c, R12a, R12b and R12c are each independently selected from H and C1-C6 alkyl;
- or
- R11a and R12a together with the carbon atom to which they are attached form a 3- to 8-membered cycloalkyl group;
- or
- R11b and R12b together with the carbon atom to which they are attached form a 3- to 8-membered cycloalkyl group;
- or
- R11c and R12c together with the carbon atom to which they are attached form a 3- to 8-membered cycloalkyl group;
- R13 is selected from (C1-C3 alkyl)-C(O)NR22R23;
- (C1-C3 alkyl)-C(O)OR23;
- and (C1-C3 alkyl)-NR23C(O)R22
- R15 and R17 are each independently selected from H and C1-C6 alkyl;
- R16 is selected from C1-C8 alkyl, aryl and a 3- to 14-membered heterocyclic group, the heterocyclic group including one or more heteroatoms selected from N, O and S;
- Z is independently selected from —OH, aryl, —O-aryl, C7-C14 aralkyl, —O—C7-C14 aralkyl, C1-C6 alkyl, C1-C6 alkoxy, —NR19(SO2)R21, —(SO2)NR19R21, —(SO2)R20, —NR19C(O)R20, —C(O)NR19R20, —NR19C(O)NR20R18, —NR19C(O)OR20, —NR19R21, C(O)OR19, —C(O)R19, SR19, —OR19, oxo, CN, NO2, and halogen, wherein the alkyl, alkoxy, aralkyl and aryl groups are each optionally substituted by one or more substituents selected from OH, halogen, C1-C4 haloalkyl and C1-C4 alkoxy;
- R18, R20 and R22 are each independently selected from H and C1-C6 alkyl;
- R19, R21 and R23 are each independently selected from H;
- C1-C8 alkyl;
- C3-C8 cycloalkyl;
- C1-C4 alkoxy-C1-C4 alkyl;
- (C0-C4 alkyl)-aryl optionally substituted by one or more groups selected from C1-C6 alkyl, C1-C6 alkoxy and halogen;
- (C0-C4 alkyl)-3- to 14-membered heterocyclic group, the heterocyclic group including one or more heteroatoms selected from N, O and S, optionally substituted by one or more groups selected from halogen, oxo, C1-C6 alkyl and —C(O)C1-C6 alkyl;
- —(C0-C4 alkyl)-O-aryl optionally substituted by one or more groups selected from C1-C6 alkyl, C1-C6 alkoxy and halogen;
- and (C0-C4 alkyl)-O-3- to 14-membered heterocyclic group, the heterocyclic group including one or more heteroatoms selected from N, O and S, optionally substituted by one or more groups selected from halogen, C1-C6 alkyl and —C(O)C1-C6 alkyl;
- wherein the alkyl groups are optionally substituted by one or more halogen atoms, hydroxyl, C1-C4 alkoxy, —C(O)NH2, —C(O)NHC1-C6 alkyl or —C(O)N(C1-C6 alkyl)2;
- or
- R19 and R20 together with the nitrogen atom to which they are attached form a 5- to 10-membered heterocyclic group, the heterocyclic group including one or more further heteroatoms selected from N, O and S, the heterocyclic group being optionally substituted by one or more substituents selected from OH;
- halogen;
- aryl;
- 5- to 10-membered heterocyclic group including one or more heteroatoms selected from N, O and S;
- —S(O)2-aryl;
- —S(O)2—C1-C6 alkyl;
- C1-C6 alkyl optionally substituted by one or more halogen atoms;
- C1-C6 alkoxy optionally substituted by one or more OH groups or C1-C4 alkoxy;
- and C(O)OC1-C6 alkyl, wherein the aryl and heterocyclic substituent groups are themselves optionally substituted by C1-C6 alkyl, C1-C6 haloalkyl or C1-C6 alkoxy;
- or
- R19 and R21 together with the nitrogen atom to which they are attached form a 5- to 10-membered heterocyclic group, the heterocyclic group including one or more further heteroatoms selected from N, O and S, the heterocyclic group being optionally substituted by one or more substituents selected from OH;
- halogen;
- aryl;
- 5- to 10-membered heterocyclic group including one or more heteroatoms selected from N, O and S;
- —S(O)2-aryl;
- —S(O)2—C1-C6 alkyl;
- C1-C6 alkyl optionally substituted by one or more halogen atoms;
- C1-C6 alkoxy optionally substituted by one or more OH groups or C1-C4 alkoxy;
- and —C(O)OC1-C6 alkyl, wherein the aryl and heterocyclic substituent groups are themselves optionally substituted by C1-C6 alkyl, C1-C6 haloalkyl or C1-C6 alkoxy;
- or
- R18 and R20 together with the nitrogen atom to which they are attached form a 5- to 10-membered heterocyclic group, the heterocyclic group including one or more further heteroatoms selected from N, O and S, the heterocyclic group being optionally substituted by one or more substituents selected from OH;
- halogen;
- aryl;
- 5- to 10-membered heterocyclic group including one or more heteroatoms selected from N, O and S;
- —S(O)2-aryl;
- —S(O)2—C1-C6 alkyl;
- C1-C6 alkyl optionally substituted by one or more halogen atoms;
- C1-C6 alkoxy optionally substituted by one or more OH groups or C1-C4 alkoxy;
- and —C(O)OC1-C6 alkyl, wherein the aryl and heterocyclic substituent groups are themselves optionally substituted by C1-C6 alkyl, C1-C6 haloalkyl or C1-C6 alkoxy;
- or
- R22 and R23 together with the atom(s) to which they are attached form a 5- to 10-membered heterocyclic group, the heterocyclic group including one or more further heteroatoms selected from N, O and S, the heterocyclic group being optionally substituted by one or more Z groups;
- m is 0, 1, 2 or 3;
- n is 0, 1, 2 or 3;
- p is 0, 1, 2 or 3;
- wherein at least one of m, n or p is not 0.
70 more elements
Dependencies are inferred from the claim text.